Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
American Journal of Hematology|January 4, 2012
Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemiaLalit Saini, Mark D Minden, Andre C Schuh, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 21, 2018
A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapyJoseph M Brandwein, Jack T Seki, Eshetu G Atenafu, et al.Journal of Geriatric Oncology|May 7, 2015
Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of ageShabbir M H Alibhai, Henriette Breunis, Narhari Timilshina, et al.British Journal of Haematology|June 2, 2012
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocolSanthosh Thyagu, Mark D Minden, Vikas Gupta, et al.Blood|December 26, 2008
A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopeniaNancy M Heddle, Richard J Cook, Alan Tinmouth, et al.Blood|January 31, 2013
Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasmsJames A Kennedy, Eshetu G Atenafu, Hans A Messner, et al.Leukemia & Lymphoma|February 28, 2007
Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years)Bruno C Medeiros, Mark D Minden, Andre C Schuh, et al.British Journal of Haematology|May 15, 2009
Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimenJohn M Storring, Mark D Minden, Susan Kao, et al.British Journal of Haematology|May 13, 2020
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapyHassan Sibai, Ruiqi Chen, Xing Liu, et al.Blood|July 10, 2014
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapyHartmut Döhner, Michael Lübbert, Walter Fiedler, et al.Pageof 6